Iron Horse Therapeutics' Series A Round

Iron Horse Therapeutics raised a round of funding on November 09, 2015.

Iron Horse Therapeutics develops novel treatments for ALS (amyotrophic lateral sclerosis) that modulate the activity of a protein called EphA4. ALS patients with reduced EphA4 expression or activity h…

Articles about Iron Horse Therapeutics' Series A Round: